Albaracin, Anita B.
HRN: 17-83-53 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/08/2023
06/15/2023
IV
4.5g
Q8
Progressing Pneumonia, CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes